Press Releases on December 18, 2023 - EIN Presswire - Press Release Distribution Service

Published on December 18, 2023 - 12:00 GMT

KopenTech announces new All-to-All trading protocol for CLO securities, completes first client trades using protocol

LOS ANGELES, Dec. 18, 2023 (GLOBE NEWSWIRE) -- KopenTech Capital Markets, LLC (“KCM”), the first online provider of electronic trading for structured products, has launched a new All-to-All trading protocol for CLO securities and successfully completed its …

Distribution channels: Banking, Finance & Investment Industry, Media, Advertising & PR ...

Published on December 18, 2023 - 12:00 GMT

Successful Transfer of New Drug Application (NDA), Acknowledged by U.S. FDA, from Former Zosano Pharma to Emergex for ...

Earlier this year, Emergex submitted a notification to the FDA regarding the transfer of ownership of Zosano Pharma’s Microneedle Array Patch (MAP) epidermal drug delivery system to Emergex itself following its acquisition of the operating assets of Zosano …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on December 18, 2023 - 12:00 GMT

Sunstone Therapies Announces Publication of Positive Phase 2 Study Results in Cancer

Sunstone Therapies Announces Publication of Positive Phase 2 Study Results in Cancer Phase 2 trial demonstrated the safety and efficacy of psilocybin-assisted group therapy for treatment of major depressive disorder in patients with cancer Group …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on December 18, 2023 - 12:00 GMT

Replay’s oncology-focused product company Syena and Miltenyi Biotec enter into exclusive licensing and GMP manufacturing agreement ...

Replay’s oncology-focused product company Syena and Miltenyi Biotec enter into exclusive licensing and GMP manufacturing agreement for PRAME TCR-NK cell therapy based on CliniMACS Prodigy® Syena secures exclusive license to Miltenyi Biotec’s PRAME TCR …

Distribution channels:

Published on December 18, 2023 - 12:00 GMT

Replay and its engineered NK cell therapy company Syena announce exclusive licensing agreement with National Institutes of Health ...

Replay and its engineered NK cell therapy company Syena announce exclusive licensing agreement with National Institutes of Health for TCRs targeting cancer neoantigens Replay and its oncology-focused product company Syena launched in collaboration with MD …

Distribution channels: Media, Advertising & PR, Technology ...

Published on December 18, 2023 - 12:00 GMT

Webuy Global to Ring NASDAQ Opening Bell Today

Singapore, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Webuy Global Ltd (Nasdaq: WBUY) (“Webuy” or the “Company”), an emerging community e-commerce retailer with a focus on grocery and travel in Southeast Asia, today announced it will celebrate the Company’s …

Distribution channels: Environment, Media, Advertising & PR ...

Published on December 18, 2023 - 12:00 GMT

New DISQO Insights: Brands Face Consumer Apprehension Headwinds in 2024

LOS ANGELES, Dec. 18, 2023 (GLOBE NEWSWIRE) -- DISQO, the leading brand experience platform, released Consumer Trends 2024, a new report revealing that people will be apprehensive, budget-conscious, and intentional about purchases in the new year. A …

Distribution channels:

Published on December 18, 2023 - 12:00 GMT

Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity ...

LONDON, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies targeting clonal neoantigens to treat solid tumors, today announced publication …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on December 18, 2023 - 12:00 GMT

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

WATERTOWN, Mass., Dec. 18, 2023 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with retinal diseases, today announced that the …

Distribution channels: Banking, Finance & Investment Industry, Technology ...

Published on December 18, 2023 - 12:00 GMT

Helium Evolution Announces Second Joint Well Encountered Helium; Completion and Testing to Proceed

CALGARY, Alberta, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Helium Evolution Incorporated (TSXV:HEVI) (“HEVI” or the “Company”), a Canadian-based helium exploration company focused on developing assets in southern Saskatchewan, is pleased to announce that its farm …

Distribution channels: Banking, Finance & Investment Industry ...

Published on December 18, 2023 - 12:00 GMT

Red Pine Intersects Significant Mineralization within a gap of the existing resource – 3.80 g/t gold over 36.94m including 11.01 g/...

TORONTO, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Red Pine Exploration Inc. (TSXV: RPX, OTCQB: RDEXF) (“Red Pine” or the “Company”) continues to report new assay results from its ongoing exploration program. These new results expand the exploration potential at …

Distribution channels: Media, Advertising & PR, Mining Industry ...

Published on December 18, 2023 - 12:00 GMT

Sonoco Implementing Price Increase for all Paperboard Converted Products

HARTSVILLE, S.C., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Sonoco (NYSE: SON) today announced it will raise the price for all converted paperboard products by a minimum of 6 percent, effective with shipments in the United States and Canada, on or after February 1 …

Distribution channels: Media, Advertising & PR, Shipping, Storage & Logistics ...

Published on December 18, 2023 - 12:00 GMT

Universal Stainless Engages EisnerAmper as New Audit Firm

BRIDGEVILLE, Pa., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Universal Stainless & Alloy Products, Inc. (Nasdaq: USAP) announced today that it has engaged and appointed EisnerAmper, LLP (“EisnerAmper”) as the Company’s independent registered public accounting …

Distribution channels: Energy Industry ...

Published on December 18, 2023 - 12:00 GMT

Invivyd Announces Positive Initial Results from Ongoing CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the ...

VYD222 produced high serum virus neutralizing antibody titer levels in immunocompromised participants Data supportive of an immunobridging approach to the EVADE study of adintrevimab Overall favorable safety and tolerability profile of VYD222 including no …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on December 18, 2023 - 12:00 GMT

Eloro Resources Intersects 279.22 g Ag/t, 0.47% Pb and 0.43% Sn (339.82g Ag eq/t) over 62.84m in Definition Drilling at the Iska ...

Hole DSB-61 above also returned other well mineralized intersections as follows: 33.83 g Ag/t, 1.53% Zn, 0.93% Pb and 0.14% Sn (130.88g Ag eq/t) over 178.99m including 120.37 g Ag/t, 2.13% Zn, 1.57% Pb and 0.19% Sn (252.19g Ag eq/t) over 18.25m,175.23 g Ag …

Distribution channels:

Published on December 18, 2023 - 12:00 GMT

Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe ...

– Oral difelikefalin as adjunct to topical corticosteroids (TCS) did not demonstrate meaningful clinical benefit compared to TCS alone; As a result, Cara will discontinue its clinical program in pruritus associated with atopic dermatitis – – Late-stage …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on December 18, 2023 - 12:00 GMT

Applied UV Announces Successful Integration of Its PURO UV Disinfection and Airocide Food Preservation Units to Optimize Cost ...

New organizational structure to maximize revenue opportunities and reduce costs across several operating units Cost saving initiatives are expected to reduce ongoing operating expenses in excess of $1 million annually beginning in January 2024; Management …

Distribution channels:

Published on December 18, 2023 - 12:00 GMT

Lexeo Therapeutics Granted FDA Fast Track Designation and Orphan Drug Designation for LX2020, an AAV-Based Gene Therapy Candidate ...

NEW YORK, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer's disease, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on December 18, 2023 - 12:00 GMT

Plus Updates Financial and Cash Guidance for 2024

Plus Receives $3.3M in grant revenue in Q4 2023 Forecasts additional $6.9M of grant revenue for 2024 Enters into debt restructuring deal with Pershing Capital to reduce 2024 cash burn by $3.7M AUSTIN, Texas, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Plus …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on December 18, 2023 - 12:00 GMT

Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to ...

CINCINNATI, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (Nasdaq: BWV) ("BWB" or the “Company”) today announced the acquisition of Proteomedix AG, a private, commercial-stage diagnostics oncology company (the “Transaction”), and …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...